Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Product/R&D News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Product/R&D News
 
China Inaugurates National Center for Translational Medicine in S... 10/28/2014
SIMM Scientists Discover Novel Anti-coagulant Drug Candidate 10/27/2014
SIMM Develops Novel Drug Candidate for B Cell Acute Lymphoblastic... 10/27/2014
Chinese Scientists Discover Alphavirus with Antitumor Activity 10/23/2014
Sihuan Buys Rights of Ebola Drug from AMMS UNIT 10/10/2014
"Virological Penicillin" Found in Chinese Herbal Medicine 10/8/2014
Biostar Files Chinese Patent Application for HBV and Liver Cancer... 9/25/2014
Sino-French Research Team Finds Potential HIV Vaccine 9/18/2014
Research Team under SIMM Discovers Lead Compound to Potential Ant... 8/14/2014
Pfizer Announces China Phase III and IV Results for Lyrica (Prega... 8/13/2014
SIMM Announces Discovery of Two New VEGFR-2 Inhibitor Series 7/28/2014
Six Chinese Pharma Companies Granted Clinical Trial Approvals for... 7/28/2014
GW and PKU Medical Division Receive Grant to Study Common Blood C... (free) 7/16/2014
Beike Biotech's Stem Cell Treatment IND Accepted for Final CFDA A... 7/10/2014
Pharmalink Granted Chinese and Other Patents for Renal Orphan Dru... 7/10/2014
Uni-Bio's Once-Daily Osteoporosis Drug Meets Phase III Primay End... 6/30/2014
Humanwell Cleared by CFDA for Phase I Trial of Class 1.1. New Art... 6/24/2014
Public Funding and Private Investment for R&D: A Survey in China'... 6/12/2014
RuiYi, iHuman Enter Partnership for New Antibodies Targeting GPCR... 6/12/2014
Chi-Med Initiates Phase II Clinical Trial for NSCLC Cancer Drug C... 6/6/2014
Review of Antibody Drug-Related Patent Applications in China 6/4/2014
Page:2/2    Total number of articles:51  :[1][2]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links